NephroSant, Inc.
Biotechnology Research
1900 Alameda De Las Pulgas
5 employees
- Employees
- 5
- Contacts
- 2
- Emails
- 2
- Phones
- 2
NephroSant, Inc. Overview
- Headquarters
- 1900 Alameda De Las Pulgas
- Phone Number
- Available in AeroLeads
- Website
- nephrosant.com
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2017
- Funding
- 16.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About NephroSant, Inc.
Kidney transplantation is the treatment of choice for patients with end-stage kidney failure. However, the life of a kidney transplant is limited due to unrecognized immune injury. There is no sensitive, non-invasive method to detect this injury at an early-stage. We have developed a reliable, inexpensive, and noninvasive assay to monitor kidney injury.
NephroSant, Inc. Contact Details
- People in AeroLeads
- 2
- With contact data
- 2
- Email contacts
- 2
- 100.0% coverage
- Phone contacts
- 2
- 100.0% coverage
NephroSant, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Richard Barnett, Nacd.dc | Corporate Board Member & Healthcare | Vancouver, Washington, United States |
Email
Phone
|
| Steve Phillips | Group Vice President, Davita | Denver, Colorado, United States |
Email
Phone
|
Compare Similar Companies to NephroSant, Inc.
CareDx, Inc.
Biotechnology Research
Slingshot Biosciences
Biotechnology Research
Renalytix
Biotechnology Research
Nephros
Biotechnology
Tenon Medical, Inc.
Medical Equipment Manufacturing
Glyphic Biotechnologies
Biotechnology Research
Verici Dx
Biotechnology
Pier 70 Ventures
Venture Capital And Private Equity Principals
Esperto Medical
Medical Equipment Manufacturing
CpG Diagnostics, Inc.
Medical And Diagnostic Laboratories